Heart Failure Module

Learn more about our AI-based solution to effectively predict and treat heart failure.

Request a demo

Heart failure management technologies to predict adverse event, improve life expectancy and cut the costs of hospital readmission.

Implicity platform is the only platform aggregating and processing data from cardiac implantable electronic devices and weight scales. A considerable portion of heart failure patients are also implanted with CIEDs. Having all data in one platform is extremely convenient and useful for managing patient clinical situation. Patients benefit from personalized support, which helps improve their quality of life from the comfort of their homes.

As for physicians, they have access to an operational solution that allows for preventive management of patient condition evolution.  By avoiding hospitalization, Implicity Heart Failure solution also meets the challenges of healthcare costs control.


This solution is available only in France for the moment.

Features

An alert is automatically generated when the algorithm identifies a higher weight or no weighing (CE marked algorithm)

Product and Services to improve clinical outcome

One global platform – Implicity platform aggregates and process data from implantable cardiac devices and weight scales

*

High reliability Withings scale connected to Implicity platform

CE marked algorithms to detect weight gain or missing data from non-usage of the scale

r

Specific alert management services by 1 nurse along with therapeutic support

Withings is not owned by Implicity.

Implicity platform makes it possible to monitor patients with cardiac devices and patients with heart failure on a single interface. Having all their data and information in a single platform saves time and enables early diagnosis of cardiac decompensations.

Weight alerts triage is performed by a nurse offered by Implicity. This service allows early access to alerts through facilitated discussions with the Implicity nurse and helps achieve a significant gain of time.

Dr. Jérôme Thévenin

Hôpital Privé de la Loire, Saint-Étienne

Request a demo

Eager to test the latest technology in remote cardiac monitoring ?
Submit

Newsletter

Would you like to learn about the latest MedTech innovations and receive medical news straight to your email inbox?
Sign up for our Newsletter

The Heart Failure Analysis Solution is a class IIa (under Regulation 2017/745) medical device designed to help heart specialists monitor weight variations for heart failure patients. Integrated within a remote monitoring solution such as the Implicity platform, the software module analyzes the weight data provided by the connected weight scale and triggers alerts for variations that are deemed significant according to medical guidelines. Read carefully all instructions before use. Covered by the French health insurance system under the “ETAPES” program.
Developed and distributed by Implicity, simplified joint-stock company with a capital of €188.272.80, registered in the Nanterre Business Register under number 820 529 089 and located at 11 Rue Louis Rolland, 92120 Montrouge (France).
Last modified: May 12, 2021